Lung Cancer News

Asian and Black patients with lung cancer experienced longer delays to radiation treatment than their white counterparts, according to study results published in Health Equity.

Only 30% of individuals with neuroendocrine tumors rank living longer as their single top priority in treating their cancer, according to a study conducted by researchers at City of Hope.

Patient withdrawal from cancer clinical trials can result in systematic bias, insufficiently powered studies and a loss of valuable scientific knowledge, according to a study in JAMA Network Open.

Tarlatamab showed encouraging response durability among heavily pretreated patients with small cell lung cancer, according to study results.

The addition of serplulimab to chemotherapy extended OS among patients with previously untreated extensive-stage small cell lung cancer, according to randomized phase 3 study results.

High-intensity aerobic exercise may decrease the risk for cancer metastasis by 72%, according to a study conducted at Tel Aviv University.

Frequent postoperative surveillance imaging after lung cancer resection did not improve outcomes for patients with stage I non-small cell lung cancer, according to data published in Journal of the National Cancer Institute.

An artificial intelligence tool predicted a person’s lung cancer risk after analyzing a single low-dose CT scan, according to study results.

Liquid biopsy effectively predicted survival outcomes among a cohort of patients with various metastatic cancer types, according to study results published in Annals of Oncology.

The FDA approved pembrolizumab as adjuvant treatment for patients with stage IB, stage II or stage IIIA non-small cell lung cancer after resection and platinum-based chemotherapy.